期刊文献+

GPI锚定B7蛋白对原发性肝癌的免疫治疗作用 被引量:1

The effect of tumor cell membranes anchored by glycosyl-phosphatidylinositol-B7-1 protein on the immuno-regulatory activity for hepatocellular carcinoma
原文传递
导出
摘要 目的GPI—B7—1蛋白转移修饰肝癌细胞膜,观察其对肿瘤细胞的免疫诱导效应。方法GPI—B7—1和B7—1蛋白修饰肝癌细胞膜,流式法测定其CD80(B7—1)的表达,分离患者外周血T细胞,检测不同蛋白修饰的肝癌细胞膜对T淋巴细胞的致增殖效应及granzyme B、perforin、IFN-γ mRNA表达的影响。结果GPI—B7-1蛋白修饰肝癌细胞膜表面B7—1表达率为85%。GPI—B7—1蛋白修饰的肝癌细胞膜致T淋巴细胞的增殖程度显著强于对照组和B7—1蛋白修饰组(P〈0.01);该作用源于其可上调肝癌外周血T淋巴细胞granzyme B、perforin及IFN-γ mRNA表达水平。结论GPI—B7—1蛋白转移修饰的肝癌细胞膜可上调granzyme B、perforin及IFN-γ mRNA表达,激活T细胞增殖,促进杀伤性T细胞的效应。 Objective To use isolated tumor membranes modified by transfer of a glycosyl-phosphatidylinositol (GPI)-anchored form of the eostimulatory molecule,B7-1 (CD80),as a cell free cancer vaccine for hepatocellular carcinoma ( HCC ) immunity. Methods Isolated tumor cell membranes were prepared from surgically removed HCC tissue. GPI-B7-1 was transferred optimally onto isolated HCC cell membranes at physiological temperature (37 ℃ ). Flow cytometry was used to directly detect the expression of B7-1 on isolated membranes. T cells were isolated from peripheral blood of patients with HCC. T cell stimulation assays were carried out for 72 h, followed by other 4-h incubation by adding 0.5 g/L MTT (final concentration) per well. The absorbanee (A) was read on an ELISA reader. The expression of granzyme B,perforin and IFN-γ/mRNA was detected by real-time PCR. Results Transfer of GPI-B7-1 to isolated membranes resulted in the stable expression, with strong effect to costimulate T cells (P 〈 0.01 ). There were high expression levels of granzyme B, perforin and IFN-γ/ mRNA from T cells. Conclusion Transfer of GPI-B7-1 to isolated HCC cell membranes could up-regulate the expression of granzyme B, perfofin and IFN-γ mRNA, activate proliferation of T cells, and promote the effects of killing T cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第11期1447-1449,共3页 Chinese Journal of Experimental Surgery
基金 浙江省科技计划重点科研项目(2005C23001) 浙江省医药卫生科技计划资助项目(2005A048)
关键词 肝细胞 蛋白转移 锚定蛋白 肿瘤疫苗 Carcinoma, hepatocellular Protein transfer Anchoring protein Tumor vactines
  • 相关文献

参考文献6

  • 1Medof ME, Nagarajan S, Tykocinski ML. Cell-surface engineering with GPI-anchored proteins. FASEB J, 1996,10:574-586.
  • 2Sun Y, Chen T, Xu Q. Si-Ni-San, a traditional Chinese prescription, and its drug-pairs suppress contact sensitivity in mice via inhibition of the activity of metalloproteinases and adhesion of T lymphocytes. J Pharm Pharmacol,2003,55:839-846.
  • 3Hayakawa M, Kawaguchi S, Ishii S, et al. B7-1-transfected tumor vaccine counteracts chemotherapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells. Int J Cancer, 1997,71 : 1091-1102.
  • 4Yang S, Darrow TL, Seigler HF. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphoeytes by B7 gene-modified melanoma cells. Cancer Res, 1997,57 : 1561-1568.
  • 5Ikezawa H. Glycosyl-phosphatidylinositol ( GPI ) -anchored-proteins. Biol Pharm Bull,2002,25:409-417.
  • 6王建伟,刘颖斌,曹岩菁,王许安,李江涛,孔颖,马孝明,彭淑牖.人B7-1基因与GPI信号肽序列融和基因的原核表达载体的构建及表达[J].中华普通外科杂志,2009,24(1):38-41. 被引量:1

二级参考文献6

同被引文献12

  • 1Zang Z, Mahendran R, Wu Q, et al. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors. Int J Mol Med ,2004 ,14 :713-717.
  • 2Qinghui W, Ratha M, Kesavan E. Nonviral cytokine cancer model. Clinical Cancer Research,2003,9:4522-4528.
  • 3Hsieh SA, Hwang LH, Hsiang A. Induction of antitumor immunity with Combination of HER2/neu DNA vaccine and interleukin 2 gene modified tumor. Clinical Cancer Research ,2004,291:231-240.
  • 4Jocham D, Richter A, Hoffmann L, et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III randomised controlled trial. Lancet ,2004,363:594-599.
  • 5Gottesman MM. Cancer gene therapy : an awkward adolescence. Cancer Gene Ther,2003 ,10 :50-58.
  • 6Wysocki PJ, Karczewska-Dzionk A, Mackiewicz-Wysoeka M, et al. Human cancer gene therapy with cytokine gene modified ceils. Expert Opin Biol Ther,2004,4 : 1595-1597.
  • 7Murphy A, Westwood JA, Teng MW, et al. Gene modification strategies to induce tumor immunity. Immunity,2005,22:403-514.
  • 8Sano T, Cantor CR. Streptavidin-containing chimeric proteins:design and production. Methods Enzymo1,2000,326:305-311.
  • 9Gao J, Huang S, Li M, et al. GM-CS17-modified mouse B16. F10 melanoma whole cell vaccine. Vaccine ,2006,24:5265-5268.
  • 10Hu ZM, Tan WL, Zhang L, et al. A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF. J Cell Mol Med ,2010,14 : 1836-1844.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部